Influence of environmental factors and diet on inflammatory bowel diseases – a review of the literature
DOI:
https://doi.org/10.12775/QS.2024.18.51011Keywords
inflammatory bowel diseases, diet, lifestyle, environmental factor, stressAbstract
Introduction and objective
Inflammatory bowel disease (IBD), leading to inflammation in the gastrointestinal tract, causes a number of bothersome symptoms that contribute to the deterioration of patients' quality of life both physically and psychologically. Therapy methods based on pharmacotherapy in IBD often remain insufficient in the treatment of these disorders, so other factors affecting the course of IBD are being sought. The purpose of this review is to present risk and prevention factors for the development of inflammatory bowel disease based on diet and environmental factors.
Abbreviated description of the state of knowledge
The review has identified a number of factors that influence IBD. One of these is smoking, which shows a commonly detrimental effect on CD, while it has a protective effect in UC patients. Antibiotic therapy, by disrupting the composition of the endogenous intestinal microflora, contributes to an increased risk of IBD exacerbations. A review of the literature on surgical interventions does not allow a clear conclusion. Stress and psychiatric disorders increasing the production of pro-inflammatory cytokines, inhibiting the anti-inflammatory action of the vagus nerve increase the risk of IBD exacerbations. A healthy and balanced diet is an important aspect in the treatment of UC and CD. Scientific societies unanimously recognize breastfeeding and its effect on the development of the intestinal microflora as an important protective factor. On the other hand, introducing an elimination diet without a food intolerance confirmed by a blood test is unjustified and harmful.
Summary
Awareness of the risk factors for development and exacerbations in IBD patients is crucial. Further research into the impact of diet and environmental factors may support pharmacological treatment in achieving therapeutic success in patients with inflammatory bowel disease.
References
Ananthakrishnan AN, Bernstein CN, Iliopoulos D, et al. Environmental triggers in IBD: a review of progress and evidence. Nat Rev Gastroenterol Hepatol. 2018 Jan;15(1):39-49. doi: 10.1038/nrgastro.2017.136.
Seyedian SS, Nokhostin F, Malamir MD. A review of the diagnosis, prevention, and treatment methods of inflammatory bowel disease. J Med Life. 2019 Apr-Jun;12(2):113-122. doi: 10.25122/jml-2018-0075.
Zhao M, Feng R, Ben-Horin S, et al. Systematic review with meta-analysis: environmental and dietary differences of inflammatory bowel disease in Eastern and Western populations. Aliment Pharmacol Ther. 2022 Feb;55(3):266-276. doi: 10.1111/apt.16703.
M'Koma AE. The Multifactorial Etiopathogeneses Interplay of Inflammatory Bowel Disease: An Overview. Gastrointest Disord (Basel). 2019 Mar;1(1):75-105. doi: 10.3390/gidisord1010007.
M'Koma AE. Inflammatory Bowel Disease: Clinical Diagnosis and Surgical Treatment-Overview. Medicina (Kaunas). 2022 Apr 21;58(5):567. doi: 10.3390/medicina58050567.
Parra RS, Chebli JMF, Amarante HMBS, et al. Quality of life, work productivity impairment and healthcare resources in inflammatory bowel diseases in Brazil. World J Gastroenterol. 2019 Oct 14;25(38):5862-5882. doi: 10.3748/wjg.v25.i38.5862.
Ng SC, Shi HY, Hamidi N, et al. Worldwide incidence and prevalence of inflammatory bowel disease in the 21st century: a systematic review of population-based studies. Lancet. 2017 Dec 23;390(10114):2769-2778. doi: 10.1016/S0140-6736(17)32448-0.
Aniwan S, Park SH, Loftus EV Jr. Epidemiology, Natural History, and Risk Stratification of Crohn's Disease. Gastroenterol Clin North Am. 2017 Sep;46(3):463-480. doi: 10.1016/j.gtc.2017.05.003.
Khor B, Gardet A, Xavier RJ. Genetics and pathogenesis of inflammatory bowel disease. Nature. 2011 Jun 15;474(7351):307-17. doi: 10.1038/nature10209.
Raftery AL, Tsantikos E, Harris NL, et al. Links Between Inflammatory Bowel Disease and Chronic Obstructive Pulmonary Disease. Front Immunol. 2020 Sep 11;11:2144. doi: 10.3389/fimmu.2020.02144.
Allais L, Kerckhof FM, Verschuere S, et al. Chronic cigarette smoke exposure induces microbial and inflammatory shifts and mucin changes in the murine gut. Environ Microbiol. 2016 May;18(5):1352-63. doi: 10.1111/1462-2920.12934.
Nicolaides S, Vasudevan A, Long T, et al. The impact of tobacco smoking on treatment choice and efficacy in inflammatory bowel disease. Intest Res. 2021 Apr;19(2):158-170. doi: 10.5217/ir.2020.00008.
Shaw SY, Blanchard JF, Bernstein CN. Association between the use of antibiotics in the first year of life and pediatric inflammatory bowel disease. Am J Gastroenterol. 2010 Dec;105(12):2687-92. doi: 10.1038/ajg.2010.398.
Olszak T, An D, Zeissig S, et al. Microbial exposure during early life has persistent effects on natural killer T cell function. Science. 2012 Apr 27;336(6080):489-93. doi: 10.1126/science.
Kvasnovsky CL, Aujla U, Bjarnason I. Nonsteroidal anti-inflammatory drugs and exacerbations of inflammatory bowel disease. Scand J Gastroenterol. 2015 Mar;50(3):255-63. doi: 10.3109/00365521.2014.966753.
Ng SC, Tang W, Leong RW, et al. Environmental risk factors in inflammatory bowel disease: a population-based case-control study in Asia-Pacific. Gut. 2015 Jul;64(7):1063-71. doi: 10.1136/gutjnl-2014-307410.
Chu KM, Watermeyer G, Shelly L, et al. Childhood helminth exposure is protective against inflammatory bowel disease: a case control study in South Africa. Inflamm Bowel Dis. 2013 Mar;19(3):614-20. doi: 10.1097/MIB.0b013e31827f27f4.
Soon IS, Molodecky NA, Rabi DM, et al. The relationship between urban environment and the inflammatory bowel diseases: a systematic review and meta-analysis. BMC Gastroenterol. 2012 May 24;12:51. doi: 10.1186/1471-230X-12-51.
Benchimol EI, Kaplan GG, Otley AR, et al. Rural and Urban Residence During Early Life is Associated with Risk of Inflammatory Bowel Disease: A Population-Based Inception and Birth Cohort Study. Am J Gastroenterol. 2017 Sep;112(9):1412-1422. doi: 10.1038/ajg.2017.208.
Deng P, Wu J. Meta-analysis of the association between appendiceal orifice inflammation and appendectomy and ulcerative colitis. Rev Esp Enferm Dig. 2016 Jul;108(7):401-10. doi: 10.17235/reed.2016.4176/2015.
Kaplan GG, Jackson T, Sands BE, et al. The risk of developing Crohn's disease after an appendectomy: a meta-analysis. Am J Gastroenterol. 2008 Nov;103(11):2925-31. doi: 10.1111/j.1572-0241.2008.02118.x.
Sun W, Han X, Wu S, et al. Tonsillectomy and the risk of inflammatory bowel disease: A systematic review and meta-analysis. J Gastroenterol Hepatol. 2016 Jun;31(6):1085-94. doi: 10.1111/jgh.13273.
Sun Y, Li L, Xie R, et al. Stress Triggers Flare of Inflammatory Bowel Disease in Children and Adults. Front Pediatr. 2019 Oct 24;7:432. doi: 10.3389/fped.2019.00432.
Bonaz B, Sinniger V, Pellissier S. Therapeutic Potential of Vagus Nerve Stimulation for Inflammatory Bowel Diseases. Front Neurosci. 2021 Mar 22;15:650971. doi: 10.3389/fnins.2021.650971.
Ge L, Liu S, Li S, et al. Psychological stress in inflammatory bowel disease: Psychoneuroimmunological insights into bidirectional gut-brain communications. Front Immunol. 2022 Oct 6;13:1016578. doi: 10.3389/fimmu.2022.1016578.
Bergeron F, Bouin M, D'Aoust L, et al. Food avoidance in patients with inflammatory bowel disease: What, when and who? Clin Nutr. 2018 Jun;37(3):884-889. doi: 10.1016/j.clnu.2017.03.010.
Crooks B, McLaughlin J, Matsuoka K, et al. The dietary practices and beliefs of people living with inactive ulcerative colitis. Eur J Gastroenterol Hepatol. 2021 Mar 1;33(3):372-379. doi: 10.1097/MEG.0000000000001911.
Zmora N, Suez J, Elinav E. You are what you eat: diet, health and the gut microbiota. Nat Rev Gastroenterol Hepatol. 2019 Jan;16(1):35-56. doi: 10.1038/s41575-018-0061-2.
Johnson CC, Ownby DR. The infant gut bacterial microbiota and risk of pediatric asthma and allergic diseases. Transl Res. 2017 Jan;179:60-70. doi: 10.1016/j.trsl.2016.06.010.
Xu L, Lochhead P, Ko Y, et al. Systematic review with meta-analysis: breastfeeding and the risk of Crohn's disease and ulcerative colitis. Aliment Pharmacol Ther. 2017 Nov;46(9):780-789. doi: 10.1111/apt.14291.
Halmos EP, Gibson PR. Dietary management of IBD--insights and advice. Nat Rev Gastroenterol Hepatol. 2015 Mar;12(3):133-46. doi: 10.1038/nrgastro.2015.11.
Cohen AB, Lee D, Long MD, et al. Dietary patterns and self-reported associations of diet with symptoms of inflammatory bowel disease. Dig Dis Sci. 2013 May;58(5):1322-8. doi: 10.1007/s10620-012-2373-3.
Eadala P, Matthews SB, Waud JP, et al. Association of lactose sensitivity with inflammatory bowel disease--demonstrated by analysis of genetic polymorphism, breath gases and symptoms. Aliment Pharmacol Ther. 2011 Oct;34(7):735-46. doi: 10.1111/j.1365-2036.2011.04799.x.
Domżał-Magrowska D, Kowalski MK, Szcześniak P, et al. The prevalence of celiac disease in patients with irritable bowel syndrome and its subtypes. Prz Gastroenterol. 2016;11(4):276-281. doi: 10.5114/pg.2016.57941.
Shoda R, Matsueda K, Yamato S, et al. Epidemiologic analysis of Crohn disease in Japan: increased dietary intake of n-6 polyunsaturated fatty acids and animal protein relates to the increased incidence of Crohn disease in Japan. Am J Clin Nutr. 1996 May;63(5):741-5. doi: 10.1093/ajcn/63.5.741.
Lima CA, Lyra AC, Rocha R, et al. Risk factors for osteoporosis in inflammatory bowel disease patients. World J Gastrointest Pathophysiol. 2015 Nov 15;6(4):210-8. doi: 10.4291/wjgp.v6.i4.210.
Dionne J, Ford AC, Yuan Y, et al. A Systematic Review and Meta-Analysis Evaluating the Efficacy of a Gluten-Free Diet and a Low FODMAPs Diet in Treating Symptoms of Irritable Bowel Syndrome. Am J Gastroenterol. 2018 Sep;113(9):1290-1300. doi: 10.1038/s41395-018-0195-4.
Limketkai BN, Sepulveda R, Hing T, et al. Prevalence and factors associated with gluten sensitivity in inflammatory bowel disease. Scand J Gastroenterol. 2018 Feb;53(2):147-151. doi: 10.1080/00365521.2017.1409364.
Owczarek D, Rodacki T, Domagała-Rodacka R, et al. World J Gastroenterol. 2016 Jan 21;22(3):895-905. doi: 10.3748/wjg.v22.i3.895.
Reif S, Klein I, Lubin F, et al. Pre-illness dietary factors in inflammatory bowel disease. Gut. 1997 Jun;40(6):754-60. doi: 10.1136/gut.40.6.754.
Russel MG, Engels LG, Muris JW, et al. Modern life' in the epidemiology of inflammatory bowel disease: a case-control study with special emphasis on nutritional factors. Eur J Gastroenterol Hepatol. 1998 Mar;10(3):243-9. doi: 10.1097/00042737-199803000-00010.
Sakamoto N, Kono S, Wakai K, et al. Dietary risk factors for inflammatory bowel disease: a multicenter case-control study in Japan. Inflamm Bowel Dis. 2005 Feb;11(2):154-63. doi: 10.1097/00054725-200502000-00009.
Ananthakrishnan AN, Khalili H, Konijeti GG, et al. Long-term intake of dietary fat and risk of ulcerative colitis and Crohn's disease. Gut. 2014 May;63(5):776-84. doi: 10.1136/gutjnl-2013-305304.
John S, Luben R, Shrestha SS, et al. Dietary n-3 polyunsaturated fatty acids and the aetiology of ulcerative colitis: a UK prospective cohort study. Eur J Gastroenterol Hepatol. 2010 May;22(5):602-6. doi: 10.1097/MEG.0b013e3283352d05.
Amre DK, D'Souza S, Morgan K, et al. Imbalances in dietary consumption of fatty acids, vegetables, and fruits are associated with risk for Crohn's disease in children. Am J Gastroenterol. 2007 Sep;102(9):2016-25. doi: 10.1111/j.1572-0241.2007.01411.x.
Ge J, Han TJ, Liu J, et al. Meat intake and risk of inflammatory bowel disease: A meta-analysis. Turk J Gastroenterol. 2015 Nov;26(6):492-7. doi: 10.5152/tjg.2015.0106.
Le Leu RK, Young GP. Fermentation of starch and protein in the colon: implications for genomic instability. Cancer Biol Ther. 2007 Feb;6(2):259-60. doi: 10.4161/cbt.6.2.4078.
Turner D, Levine A, Escher JC, et al.; European Crohn's and Colitis Organization; European Society for Paediatric Gastroenterology, Hepatology, and Nutrition. Management of pediatric ulcerative colitis: joint ECCO and ESPGHAN evidence-based consensus guidelines. J Pediatr Gastroenterol Nutr. 2012 Sep;55(3):340-61. doi: 10.1097/MPG.0b013e3182662233.
Dziechciarz P, Horvath A, Shamir R, et al. Meta-analysis: enteral nutrition in active Crohn's disease in children. Aliment Pharmacol Ther. 2007 Sep 15;26(6):795-806. doi: 10.1111/j.1365-2036.2007.03431.x.
Bishop J, Lemberg DA, Day A. Managing inflammatory bowel disease in adolescent patients. Adolesc Health Med Ther. 2014 Jan 6;5:1-13. doi: 10.2147/AHMT.S37956.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2024 Ewelina Wesolek, Kinga Knop-Chodyła, Anna Kochanowska-Mazurek, Zuzanna Piasecka, Aneta Głaz, Karolina Pawelec, Albert Bielaska, Grzegorz Jama
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
Stats
Number of views and downloads: 176
Number of citations: 0